Expression of the nonclassical HLA-G and HLA-E molecules in laryngeal lesions as biomarkers of tumor invasiveness

Histology and Histopathology

Volumn 26, Issue 12, 2011, Pages 1487-1497

  Silva, Tarsia G ^a   Crispim, Janaina C O ^b,c   Miranda, Fabiana A ^c   Hassumi, Marcela K ^c   de Mello, Júlia M Y ^a   Simões, Renata T ^c   Souto, Francisco ^d   Soares, Edson G ^c   Donadi, Eduardo A ^c   Soares, Christiane Pienna ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

Author keywords

Biomarkers; HLA E; HLA G; HPV; Laryngeal lesions

Indexed keywords

HLA ANTIGEN CLASS 1; HLA E ANTIGEN; HLA G ANTIGEN; HLA-E ANTIGEN; TUMOR MARKER; VIRUS DNA;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BIOPSY; BRAZIL; CANCER INVASION; CARCINOMA; CARCINOMA IN SITU; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LARYNX TUMOR; LYMPH NODE; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; PAPILLOMA; PAPILLOMA VIRUS; PATHOLOGY; POLYMERASE CHAIN REACTION; PRECANCER; RISK; VIROLOGY;

ADULT; AGED; ANALYSIS OF VARIANCE; BIOPSY; BRAZIL; CARCINOMA; CARCINOMA IN SITU; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-G ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; ODDS RATIO; PAPILLOMA; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; TUMOR MARKERS, BIOLOGICAL;

HUMAN PAPILLOMAVIRUS;

EID: 80053940545     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Bettini J. de S., Soares E.G., Duarte G., Simões R.T. and Simões A.L. (2003). PCR diagnosis of HPV in cervical biopsies of CIN and invasive neoplasia formerly diagnosed as HPV negative. Acta Cytol. 47, 545-549.
2. Braud V.M., Allan D.S., O'Callaghan C.A., Söderström K., D'Andrea A., Ogg G.S., Lazetic S., Young N.T., Bell J.I., Phillips J.H., Lanier L.L. and McMichael A.J. (1998). HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391, 795-799.
3. Cardili R.N., Alves T.G., Freitas J.C., Soares C.P., Mendes-Junior C.T., Soares E.G., Donadi E.A. and Silva-Souza C. (2010). Expression of HLA-G primarily targets affected skin of psoriasis patients. Br. J. Dermatol. 163, 769-775.
4. Carosella E.D., Favier B., Rouas-Freiss N., Moreau P. and Lemaoult J. (2008). Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 111 4862-4870.
5. Caumartin J., Favier B., Daouya. M., Guillard. C., Moreau P., Carosella E.D. and LeMaoult J. (2007). Trogocytosis-based generation of suppressive NK cells. EMBO J. 26, 1423-1433.
6. Contini P., Ghio M., Poggi A., Filaci G., Indiveri F., Ferrone S. and Puppo F. (2003). Soluble HLA-A,-B,-C and-G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur. J. Immunol. 33, 125-134.
7. Coupel S., Moreau A., Hamidou M., Horejsi V., Soulillou J.P. and Charreau B. (2007). The HLA Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation. Blood 109, 2806-2814.
8. Esteban F., Redondo M., Delgado M., Garrido F. and Ruiz-Cabello F. (1996). MHC class I antigens and tumor-infiltrating leucocytes in laryngeal cancer: long-term follow-up. Br. J. Cancer 74, 1801-1804.
9. Esteban F., Concha A., Delgado M., Perez-Ayala M., Ruiz Cabello F. and Garrido F. (1990). Lack of MHC class I antigens and tumor aggressiveness of the squamous cell carcinoma of the larynx. Br. J. Cancer 62, 1047-1051.
10. Favier B., LeMaoult J., Rouas-Freiss N., Moreau P., Menier C. and Carosella E.D. (2007). Research on HLA-G: an update. Tissue Antigens 69, 207-211.
11. Gazit E., Sherf M., Balbin E., Muratov A., Goldstein I. and Loewenthal R. (2007). HLA-G expression is induced in Epstein-Barr virustransformed B-cell lines by culture conditions Hum. Immunol. 68, 463-468.
12. Gonçalves M.A., Le Discorde M., Simões R.T., Rabreau M., Soares E.G., Donadi E.A. and Carosella E.D. (2008). Classical and nonclassical HLA molecules and p16INK4a expression in precursors lesions and invasive cervical cancer. Eur. J. Obstet. Gynecol. Reprod. Biol. 141, 70-74.
13. Gonen-Gross T., Achdout H., Arnon T.I., Gazit R., Stern N., Horejsí V., Goldman-Wohl D., Yagel S. and Mandelboim O. (2005). The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and {b}2-microglobulin-free HLA-G molecules. J. Immunol. 175, 4866-4874.
14. Gorgoulis G., Zacharatos P., Kotsinas A., Kyroudi A., Rassidakis A.N., Ikonomopoulos J.A., Barbatis C., Herrington C.S. and Kittas C. (1999). Human Papilloma Virus (HPV) is possibly involved in laryngeal but not in lung carcinogenesis. Hum. Pathol. 30, 274-283.
15. Guimarães M.C., Soares C.P., Donadi E.A., Derchain S.F., Andrade L.A., Silva T.G., Hassumi M.K., Simões R.T., Miranda F.A., Lira R.C., Crispim J. and Soares E.G. (2009). Low expression of human histocompatibility soluble leukocyte antigen-G (HLA-G5) in invasive cervical cancer with and without metastasis, associated with papilloma virus (HPV). J. Histochem. Cytochem. 5, 405-411.
16. Hobbs C.G., Rees L.E., Heyderman R.S., Birchall M.A. and Bailey M. (2006). Major histocompatibility complex class I expression in human tonsillar and laryngeal epithelium. Clin. Exp. Immunol.145, 365-371.
17. Joly E. and Hudrisier D. (2003). What is trogocytosis and what is its purpose? Nat. Immunol. 4, 815.
18. Koskinen W.J., Brondbo K., Mellin Dahlstrand H., Luostarinen T., Hakulinen T., Leivo I., Molijn A., Quint W.G., Roysland T., Munck-Wikland E., Mäkitie A.A., Pyykkö I., Dillner J., Vaheri A. and Aaltonen L.M. (2007). Alcohol, smoking and human papillomavirus in laryngeal carcinoma: a Nordic prospective multicenter study. J. Cancer Res. Clin. Oncol. 133, 673-678.
19. Kreimer A.R., Clifford G.M., Boyle P. and Franceschi S. (2005). Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol. Biomarkers Prev. 14, 467-475.
20. Lafon M., Prehaud C., Megret F., Lafage M., Mouillot G., Roa M., Moreau P., Rouas-Freiss N. and Carosella E.D. (2005). Modulation of HLA-G Expression in Human Neural Cells after Neurotropic Viral Infections. J. Virol. 79, 15226-15237.
21. Le Bouteiller P., Legrand-Abravanel F. and Solier C. (2003). Soluble HLA-G1 at the Materno-foetal Interface. Placenta 17, S10-S15.
22. LeMaoult J., Zafaranloo K., Le Danff C. and Carosella E.D. (2005). HLAG up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J. 19, 662-664.
23. LeMaoult J., Le Discorde M., Rouas-Freiss N., Moreau P., Menier C., McCluskey J. and Carosella E.D. (2003). Biology and functions of human leukocyte antigen-G in health and sickness. Tissue Antigens. 62, 273-284.
24. Lozano J.M., Gonzalez R., Kindelán J.M., Rouas-Freiss N, Caballos R, Dausset J, Carosella E.D. and Peña J. (2002). Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS 16, 347-351.
25. Marin R., Ruiz-Cabello F., Pedrinaci S., Méndez R., Jiménez P., Geraghty D.E. and Garrido F. (2003). Analysis of HLA-E expression in human tumors. Immunogenetics 54, 767-775.
26. Miranda F.A., Hassumi M.K., Guimarães M.C., Simões R.T., Silva T.G., Lira R.C., Rocha A.M., Mendes C.T. Jr, Donadi E.A., Soares C.P. and Soares E.G. (2009). Galectin-3 overexpression in invasive laryngeal carcinoma, assessed by computer-assisted analysis. J. Histochem. Cytochem. 57, 665-673.
27. Moreau P., Carosella E., Teyssier M., Prost S., Gluckman E., Dausset J. and Kirszenbaum M. (1995). Soluble HLA-G molecule. An alternatively spliced HLA-G mRNA form candidate to encode it in peripheral blood mononuclear cells and human trophoblasts. Hum. Immunol. 43, 231-236.
28. Muenscher A., Feucht H.H., Kutta H. and Tesche S. (2009). Integration of human papilloma virus type 26 in laryngeal cancer of a child. Auris Nasus Larynx. 36, 232-234.
29. Onno M., Pangault C., Le Friec G., Guilloux V., André P. and Fauchet R. (2000). Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J. Immunol. 164, 6426-6434.
30. Parkin D.M., Bray F., Ferlay J. and Pisani P. (2005). Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74-108.
31. Paul P., Cabestre F.A., Ibrahim E.C., Lefebvre S., Khalil-Daher I., Vazeux G., Quiles R.M., Bermond F., Dausset J. and Carosella E.D. (2000). Identification of HLA-G7 as a new splice variant of the HLAG mRNA and expression of soluble HLA-G5,-G6, and-G7 transcripts in human transfected cells. Hum. Immunol. 61, 1138-1149.
32. Rihkanen H., Peltomaa J. and Syrjanen S. (1994). Prevalence of human papillomavirus (HPV) DNA in vocal cords without laryngeal papillomas. Acta Otolaryngol. 114, 348-351.
33. Rees L.E., Ayoub O., Haverson K., Birchall M.A. and Bailey M. (2003). Differential major histocompatibility complex class II locus expression on human laryngeal epithelium. Clin. Exp. Immunol. 134, 497-502.
34. Rouas-Freiss N., Moreau P., Menier C., LeMaoult J. and Carosella E.D. (2007). Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses. Semin. Cancer Biol. 17, 413-421.
35. Sheu B.C., Chiou S.H., Chang W.C., Chow S.N., Lin H.H., Chen R.J., Huang S.C., Ho H.N. and Hsu S.M. (2005). Integration of high-risk human papillomavirus DNA correlates with HLA genotype aberration and reduced HLA class I molecule expression in human cervical carcinoma. Clin. Immunol. 115, 295-301.
36. Shiroishi M., Tsumoto K., Amano K., Shirakihara Y., Colonna M., Braud V.M., Allan D.S., Makadzange A., Rowland-Jones S., Willcox B., Jones E.Y., van der Merwe P. A., Kumagai I. and Maenaka K. (2003). Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc. Natl. Acad. Sci. USA 100, 8856-8861.
37. Singer G., Rebmann V., Chen Y. C., Liu H.T., Ali S.Z., Reinsberg J., McMaster M.T., Pfeiffer K., Chan D.W., Wardelmann E., Grosse-Wilde H., Cheng C.C., Kurman R.J. and Shih IeM. (2003). HLA-G is a potential tumor marker in malignant ascites. Clin. Cancer. Res. 9, 4460-4464.
38. Sullivan L.C., Hoare H.L., McCluskey J., Rossjohn J. and Brooks A.G. (2006). A structural perspective on MHC class. Ib molecules in adaptive immunity. Trends Immunol. 27, 413-420.
39. Ting Y. and Manos M. (1990). Detection and typing of genital human papillomaviruses. In: Polymerase chain reaction proteocols: a guide to methods and applications. Innis M.A., Gelfand D.H. and Sninsky J.J. (eds). Academic Press. San Diego. 356-367.
40. Tomasec P., Braud V.M., Rickards C. Powell M.B., McSharry B.P., Gadola S., Cerundolo V., Borysiewicz L.K., McMichael A.J. and Wilkinson G.W. (2000). Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287, 1031.
41. Walboomers J.M., Jacobs M.V., Manos M. M, Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J. and Munoz N. (1999). Human papillomavirus is a necessary cause of invasive cancer worldwide. J. Pathol. 189, 12-19.
42. Wünsch-Filho V. (2004). The epidemiology of laryngeal cancer in Brazil. Sao Paulo Med. J. 122, 188-194.
43. Zheng X.Q., Li C.C., Xu D.P., Lin A., Bao W.G., Yang G.S. and Yan W.H. (2010). Analysis of the plasma soluble human leukocyte antigen-G and interleukin-10 levels in childhood atopic asthma. Hum. Immunol. 71, 982-987.
44. Yie S.M., Yang H., Ye S.R., Li K., Dong D.D. and Lin X.M. (2007a). Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma. Am. J. Clin. Pathol. 128, 1002-1009.
45. Yie S.R., Yang H., Li K., Dong D.D., Lin X.M. and Yie S.M. (2007b). Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer. Mod. Pathol. 20, 375-383.